Johan van Hylckama - Jan 14, 2022 Form 4 Insider Report for Kaleido Biosciences, Inc. (KLDO)

Role
Chief Scientific Officer
Signature
/s/ Johan van Hylckama Vlieg
Stock symbol
KLDO
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/18/2022, 04:18 PM
Previous filing
Sep 2, 2021
Next filing
Mar 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLDO Restricted Stock Units Award $0 +350K $0.00 350K Jan 14, 2022 Common Stock 350K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
F2 The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.